Found 51 matching trials
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
Intensified Rituimab Prephase Before FCR in Untreated B-CLL PHASE2 Phase II, multicenter, randomized trial, exploring intensified Rituximab pr...
Show More Location
Stephane LEPRETRE
Learn More & Join Trial
Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen PHASE2 Currently,6 cycles of Temozolomide adjuvant chemotherapy after concurrent r...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer PHASE2 This is an open -label randomized phase II study of dose-dense Fluorouracil...
Show More Location
AKH, Universitätsklinik für Innere Medizin 1
Learn More & Join Trial
Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer PHASE3 RATIONALE: Drugs used in chemotherapy, such as docetaxel, doxorubicin , cyc...
Show More Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Learn More & Join Trial
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer PHASE2 The purpose of this study is to find out if it is practical (feasible) to g...
Show More Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors NA This is a prospective multicenter, non-randomized research program that inc...
Show More Learn More & Join Trial
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer PHASE3 The primary objective of this trial is to compare the rate of pathologicall...
Show More Location
German Breast Group
Learn More & Join Trial
Regional Anesthesia in Total Hip and Knee Arthroplasty PHASE4 The purpose of this study is to test whether the use of Ropivacaine and Mep...
Show More Location
Multiple Locations
Learn More & Join Trial